Plasmablastic Lymphoma, a Rare Entity in Bone Marrow with Unusual Immunophenotype and Challenging Differential Diagnosis

Plasmablastic lymphoma (PBL) is an aggressive malignancy that usually occurs in the setting of immunosuppression. The immunohistochemical profile of PBL is that of terminally differentiated B lymphocytes. CD138, CD38, and MUM1 are usually immunopositive. However, pan B-cell markers such as CD20 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Shaarani, Majd, Shackelford, Rodney E., Master, Samip R., Mills, Glenn M., AlZubaidi, Yasir, Mamilly, Ahmed, Wei, Eric X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745100/
https://www.ncbi.nlm.nih.gov/pubmed/31565447
http://dx.doi.org/10.1155/2019/1586328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745100/
https://www.ncbi.nlm.nih.gov/pubmed/31565447
http://dx.doi.org/10.1155/2019/1586328

Ejemplares similares